Loading stock data…
Boston Scientific Corporation develops (BSX)
$43.48-0.75 (-1.70%)
Market ClosedLast close Jun 29
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Boston Scientific Corporation in the Healthcare sector is trading at $43.48 with a market capitalization of $69.1B. Wall Street consensus targets $75.00 (29 analysts), implying a +72.5% move over the next 12 months. The stock is currently near its 52-week low of $43.37, remaining 45.2% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: RSI 22 is oversold, raising the odds of a near-term bounce. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +72.5% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 22) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $5.20B↓ | $5.29B↑ | $5.07B | $5.06B↑ | $4.66B |
| Gross Profit | $3.61B↓ | $3.68B↑ | $3.54B↑ | $3.42B↑ | $3.21B |
| Operating Income | $1.07B↑ | $1.04B↓ | $1.05B↑ | $943.00M↑ | $937.00M |
| Net Income | $1.34B↑ | $672.00M↓ | $755.00M↓ | $797.00M↑ | $674.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and tre...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$69.09B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
13.78%
Volume
Today's trading volume
21.48M
Recent News
Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic
Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.
3 Value Stocks to Research Further
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
Is Boston Scientific (BSX) One of the Best Low Volatility Stocks to Buy Under $50?
Boston Scientific Corporation (NYSE:BSX) is one of the best low volatility stocks to buy under $50. BofA cut the price target on Boston Scientific Corporation (NYSE:BSX) to $61 from $68 on June 12 and maintained a Buy rating on the shares. It noted that the firm’s services team continues to highlight a lower utilization environment, […]
2 Healthcare Stocks for Long-Term Investors and 1 We Brush Off
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 9.5% over the past six months while the S&P 500 was up 6.2%.
TD Cowen Maintains a Buy Rating on Boston Scientific (BSX)
Boston Scientific Corporation (NYSE:BSX) is one of the Stocks Expected to Bounce Back According to Analysts. The stock has fallen more than 52% year-to-date, but the Street expects more than 65% upside from the current level. Recently, on June 16, TD Cowen analyst Josh Jennings maintained his Buy rating on Boston Scientific Corporation (NYSE:BSX) with […]